Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories may also be marketed in certain international locations. In Eire, new restrictions arrived into effect on 1 August 2010[ninety] regarding... https://www.codeingil.com/